查询日期：
年
资产配置(2022-12-31)
| 资产类型 | 金额（元） | 占基金总资产的比例 |
|---|
| 权益投资 |
46,831,546.36 |
92.10% |
| 银行存款和结算备付金合计 |
3,854,935.03 |
7.58% |
| 其他各项资产 |
164,025.78 |
0.32% |
| 合计 |
50,850,507.17 |
100.00% |
投资组合(2022-12-31)
占基金资产净值前十名股票及存托凭证投资明细
| 序号 |
公司名称（英文） |
证券代码 |
数量(股) |
公允价值(元) |
占基金资产净值比例(%) |
| 1 |
Align Technology Inc |
ALGN US |
567 |
832,828.96 |
1.67%
|
| 2 |
Universal Health Services Inc |
UHS US |
841 |
825,224.94 |
1.65%
|
| 3 |
Cooper Cos Inc/The |
COO US |
346 |
796,832.56 |
1.59%
|
| 4 |
DENTSPLY SIRONA Inc |
XRAY US |
3,539 |
784,783.39 |
1.57%
|
| 5 |
Quest Diagnostics Inc |
DGX US |
720 |
784,470.26 |
1.57%
|
| 6 |
Charles River Laboratories International Inc |
CRL US |
510 |
773,969.03 |
1.55%
|
| 7 |
Viatris Inc |
VTRS US |
9,935 |
770,121.44 |
1.54%
|
| 8 |
Organon & Co |
OGN US |
3,959 |
770,109.74 |
1.54%
|
| 9 |
Becton Dickinson and Co |
BDX US |
433 |
766,885.34 |
1.53%
|
| 10 |
Bio-Techne Corp |
TECH US |
1,327 |
765,978.97 |
1.53%
|
|